Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer
- 1 January 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (2) , 230-237
- https://doi.org/10.1016/0959-8049(94)00472-h
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chemotherapy for ovarian cancerEuropean Journal Of Cancer, 1993
- TaxolAnti-Cancer Drugs, 1992
- Microculture-Based Chemosensitivity Testing: A Feasibility Study Comparing Freshly Explanted Human Melanoma Cells With Human Melanoma Cell LinesJNCI Journal of the National Cancer Institute, 1992
- Mechanism of action of taxolTrends in Pharmacological Sciences, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- A phase II trial of taxol in metastatic melanomaCancer, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Taxol: an antimitotic agent with a new mechanism of actionPharmacology & Therapeutics, 1984
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971